Bone marrow-derived mononuclear cell therapy for patients with ischemic heart disease and ischemic heart failure

Bibliography

• J, Swedberg K, ClelandDargie H, Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-40
   PubMed Web of Science ®Google Scholar
• Dickstein K, Cohen-Solal A, Filippatos G, ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-89
   PubMed Web of Science ®Google Scholar
• van Ramshorst J, Rodrigo SF, Schalij MJ, Bone marrow cell injection for chronic myocardial ischemia: the past and the future. J Cardiovasc Transl Res 2011;4:182-91
   PubMed Web of Science ®Google Scholar
• Menasche P. Current status and future prospects for cell transplantation to prevent congestive heart failure. Semin Thorac Cardiovasc Surg 2008;20:131-7
   PubMedGoogle Scholar
• Turan RG, Bozdag TI, Ortak J, Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease. Stem Cell Rev 2011;7:646-56
   PubMed Web of Science ®Google Scholar
• van Ramshorst J, Bax JJ, Beeres SL, Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. Jama 2009;301:1997-2004
   PubMed Web of Science ®Google Scholar
• Ang KL, Chin D, Leyva F, Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone. Nat Clin Pract Cardiovasc Med 2008;5:663-70
   PubMedGoogle Scholar
• Yao K, Huang R, Qian J, Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function. Heart 2008;94:1147-53
   PubMed Web of Science ®Google Scholar
• Assmus B, Honold J, Schachinger V, Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006;355:1222-32
   PubMed Web of Science ®Google Scholar
• Tse HF, Thambar S, Kwong YL, Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). Eur Heart J 2007;28:2998-3005
   PubMed Web of Science ®Google Scholar
• Y, Zhao Q, SunXia L, Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery. Ann Thorac Surg 2008;86:1833-40
   PubMed Web of Science ®Google Scholar
• Perin EC, Silva GV, Henry TD, A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). Am Heart J 2011;161:1078-87
   PubMed Web of Science ®Google Scholar
• 13. Hu S, Liu S, Zheng Z, Isolated coronary artery bypass graft combined with bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: a single-center, randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 2011;57:2409-15
   Google Scholar
• Hendrikx M, Hensen K, Clijsters C, Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 2006;114:I101-7
   Web of Science ®Google Scholar
• Pokushalov E, Romanov A, Chernyavsky A, Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study. J Cardiovasc Transl Res 2010;3:160-8
   PubMed Web of Science ®Google Scholar
• Patel AN, Geffner L, Vina RF, Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 2005;130:1631-8
   PubMed Web of Science ®Google Scholar
• Perin EC, Willerson JT, Pepine CJ, Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart Failure: the FOCUS-CCTRN Trial. Jama 2012;307:1717-26
   PubMed Web of Science ®Google Scholar
• Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323:42-6
   PubMed Web of Science ®Google Scholar
• Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13
   PubMedGoogle Scholar
• Higgins JP, Thompson SG, Deeks JJ, Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60
   PubMed Web of Science ®Google Scholar
• Janssens SP. Cardiac bone marrow cell therapy: the proof of the pudding remains in the eating. Eur Heart J 2011;32:1697-700
   PubMed Web of Science ®Google Scholar
• Brunskill SJ, Hyde CJ, Doree CJ, Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease. Eur J Heart Fail 2009;11:887-96
   PubMed Web of Science ®Google Scholar
• Fukushima S, Varela-Carver A, Coppen SR, Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation 2007;115:2254-61
   PubMed Web of Science ®Google Scholar
• Makela J, Anttila V, Ylitalo K, Acute homing of bone marrow-derived mononuclear cells in intramyocardial vs. intracoronary transplantation. Scand Cardiovasc J 2009;43:366-73
   PubMed Web of Science ®Google Scholar
• Brenner C, Franz WM. The use of stem cells for the repair of cardiac tissue in ischemic heart disease. Expert Rev Med Devices 2011;8:209-25
   PubMed Web of Science ®Google Scholar
• Siu CW, Liao SY, Liu Y, Stem cells for myocardial repair. Thromb Haemost 2010;104:6-12
   PubMed Web of Science ®Google Scholar
• Tongers J, Losordo DW, Landmesser U. Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur Heart J 2011;32:1197-206
   PubMedGoogle Scholar
• Chen S, Liu Z, Tian N, Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. J Invasive Cardiol 2006;18:552-6
   PubMedGoogle Scholar
• Zaruba MM, Huber BC, Brunner S, Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival. Cardiovasc Res 2008;77:722-31
   PubMed Web of Science ®Google Scholar
• Korf-Klingebiel M, Kempf T, Sauer T, Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J 2008;29:2851-8
   PubMed Web of Science ®Google Scholar
• Tse HF, Yiu KH, Lau CP. Bone marrow stem cell therapy for myocardial angiogenesis. Curr Vasc Pharmacol 2007;5:103-12
   PubMed Web of Science ®Google Scholar
• Zaruba MM, Theiss HD, Vallaster M, Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 2009;4:313-23
   PubMed Web of Science ®Google Scholar
• Balsam LB, Wagers AJ, Christensen JL, Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004;428:668-73
   PubMed Web of Science ®Google Scholar
• Murry CE, Soonpaa MH, Reinecke H, Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-8
   PubMed Web of Science ®Google Scholar
• Kim HW, Haider HK, Jiang S, Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J Biol Chem 2009;284:33161-8
   PubMed Web of Science ®Google Scholar
• Lu G, Haider HK, Jiang S, Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43. Circulation 2009;119:2587-96
   PubMed Web of Science ®Google Scholar
• Niagara MI, Haider H, Jiang S, Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res 2007;100:545-55
   PubMed Web of Science ®Google Scholar
• Haider H, Lee YJ, Jiang S, Phosphodiesterase inhibition with tadalafil provides longer and sustained protection of stem cells. Am J Physiol Heart Circ Physiol 2010;299:H1395-404
   PubMed Web of Science ®Google Scholar
• Abdel-Latif A, Bolli R, Tleyjeh IM, Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007;167:989-97
   PubMed Web of Science ®Google Scholar
• Martin-Rendon E, Brunskill S, Doree C, Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev 2008:CD006536
   Google Scholar
• Clifford DM, Fisher SA, Brunskill SJ, Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes. PLoS One 2012;7:e37373
   PubMed Web of Science ®Google Scholar
• Clifford DM, Fisher SA, Brunskill SJ, Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev 2012;2:CD006536
   PubMedGoogle Scholar
• Jeevanantham V, Butler M, Saad A, Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 2012;126:551-68
   PubMed Web of Science ®Google Scholar